comprehensive -WSS

comprehensive

author：hotspot 2025-09-30 14:08:52 - browse：48523

Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI, they say.

In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electrodes to record brain activity and later fed the scans into a homegrown artificial intelligence system that analyzed them for patterns. They found that it was possible to track patients’ recovery through changes in brain cells’ electrical activity.

Finding so-called biomarkers, or objective measurements reflecting depression, could help diagnose depression, track its progression, predict a relapse, and better tailor therapies to individual patients. But finding those metrics has been difficult, partly because depression’s biological impact isn’t well understood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Medical bills so high, Medicare adding extra digits to claim forms

WSS

First medicine developed to treat MASH expected to be approved soon

MassMutual is introducing free genetic testing for members

Element Biosciences CEO lays out genome sequencing strategy

Why does health care cost so much? A reading guide

UnitedHealth financials solid despite Change Healthcare cyberattack

RSV shot was 90% effective at preventing hospitalizations in kids

entertainment

comprehensive

Wikipedia

Malaria cases in Florida and Texas: Here’s what you need to know

Diversity in clinical trials starts with building trust, experts say

Jerome Adams on the need for new antivirals for Covid

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Guidelines to prevent youth baseball injuries need more muscle

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Trump demands the U.S. pay no more for drugs than other countries … again

Element Biosciences CEO lays out genome sequencing strategy

How to save PrEP access — and even expand it

Former medical device CEO who sold dummy, plastic parts convicted of fraud

focus

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Precocious puberty in girls comes with mental health risks

RSV shot was 90% effective at preventing hospitalizations in kids

Cancer researcher Catriona Jamieson is sending tumors into space

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

First medicine developed to treat MASH expected to be approved soon

knowledge

leisure time

explore

focus